Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. (Q37128253)

18 August 2017

1 reference

title

Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. (English)

1 reference

18 August 2017

0 references

0 references

Alexandre Iannello

1

1 reference

18 August 2017

Olfa Debbeche

series ordinal

2

1 reference

18 August 2017

Suzanne Samarani

series ordinal

3

1 reference

18 August 2017

Ali Ahmad

series ordinal

4

1 reference

18 August 2017

language of work or name

1 reference

3 April 2008

1 reference

Journal of Leukocyte Biology

18 August 2017

1 reference

18 August 2017

84

1 reference

18 August 2017

1-26

1 reference

18 August 2017

1

1 reference

Viral strategies for evading antiviral cellular immune responses of the host

18 August 2017

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cells in viral infection: more than just killers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human natural killer cell deficiencies and susceptibility to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Bone marrow versus thymic pathways of natural killer cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human natural killer cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NKT cells: T lymphocytes with innate effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

TGFbeta promotes conversion of CD16+ peripheral blood NK cells into CD16- NK cells with similarities to decidual NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cells trigger differentiation of monocytes into dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

When killers become helpers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

A novel dendritic cell subset involved in tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

IL-18-induced CD83+CCR7+ NK helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer type 2 bias in remission of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Possible roles of KIR2DL4 expression on uNK cells in human pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cells in antiviral defense: function and regulation by innate cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

IL-15 and HIV infection: lessons for immunotherapy and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Fas-mediated cytotoxicity by freshly isolated natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

What is the importance of the immunological synapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The activating NKG2D ligand MHC class I-related chain A transfers from target cells to NK cells in a manner that allows functional consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR and disease: a model system or system of models?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Regulation of immune responses through inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR2DL4 (CD158d) genotype influences expression and function in NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-γ Production

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Activation of NK cells by an endocytosed receptor for soluble HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: induction of IFN-gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NK cells and human pregnancy--an inflammatory view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

MHC class I-independent recognition of NK-activating receptor KIR2DS4

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Natural killer cell-mediated lysis of autologous cells modified by gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Strategies for target cell recognition by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human NKG2F is expressed and can associate with DAP12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

DAP12: an adapter protein with dual functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

MICA and MICB genes: can the enigma of their polymorphism be resolved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human natural killer cell receptors and co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Different checkpoints in human NK-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The LLT1 receptor induces IFN-gamma production by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NK cell regulation by SLAM family receptors and SAP-related adapters

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

LFA-1 contributes an early signal for NK cell cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Activation, coactivation, and costimulation of resting human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Regulation of the natural killer cell receptor repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Identification of distal KIR promoters and transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Dicing and slicing: the core machinery of the RNA interference pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Identification of bidirectional promoters in the human KIR genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Human diversity in killer cell inhibitory receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Licensing of natural killer cells by host major histocompatibility complex class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

How do natural killer cells find self to achieve tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Activation and self-tolerance of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Immunogenetics of killer cell immunoglobulin-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

The influence of HLA genotype on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cellular immune responses to HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

KIR/HLA pleiotropism: protection against both HIV and opportunistic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0907650

21 January 2018

Identifiers

DOI

10.1189/JLB.0907650

1 reference

18 August 2017

1 reference